Capa/PortadaYahoo FinancePortadaErasca (ERAS) Climbs 390% YTD on ‘Best-in-Class’ Potential of Cancer TreatmentRRedacciónRedação · ayerLeitura 2 minLer a nota completa em Yahoo Finance